Entrada Therapeutics Inc
NASDAQ:TRDA
Intrinsic Value
The intrinsic value of one
TRDA
stock under the Base Case scenario is
4.37
USD.
Compared to the current market price of 12.5 USD,
Entrada Therapeutics Inc
is
Overvalued by 65%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Entrada Therapeutics Inc.
The intrinsic value of one
TRDA
stock under the Base Case scenario is
4.37
USD.
Compared to the current market price of 12.5 USD,
Entrada Therapeutics Inc
is
Overvalued by 65%.